Onconic Therapeutics announced on September 29 that it has received approval from the Ministry of Food and Drug Safety for a Phase 2 clinical trial ...

Hanmi Pharm announced on September 29 that it has entered into a global licensing and collaboration agreement with Gilead ...

For patients with high-risk HER2-positive early breast cancer who have undergone neoadjuvant therapy, treatment with Enhertu ...

Some parents have reported positive changes in their kids after giving them the drug, but experts remain concerned about a lack of strong evidence.

EXCLUSIVE: Analysis by a charity shows almost 35,000 lives have been saved by advances in treating childhood cancer since the 1970s.

Richmond firefighter Jonathan Clarke is suing major chemical companies, alleging PFAS in his turnout gear caused leukemia.

Lean Body Mass: Improvements in lean body mass were aligned with total weight gains, suggesting preservation or accrual of muscle, consistent with pre-clinical research with ART27.13. Activity: ...

KOMET-017-IC trial of intensive chemotherapy combination will assess MRD negative CR and EFS as dual-primary endpoints to support potential ...

Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to ...

GLIX1 restores TET2 activity in cancer, resulting in double stranded DNA breaks in cancer cells only - - FDA IND clearance received for Phase 1/2a ...

Immuneering Corporation - Special CallCompany ParticipantsBenjamin Zeskind - Co-Founder, President, CEO & DirectorConference Call ...